1. Ma, Sicong, Sandhoff, Roger, Luo, Xiu, Gao, Pu, Cui, Guoliang. 2024. Serine enrichment in tumors promotes regulatory T cell accumulation through sphinganine-mediated regulation of c-Fos. In Science immunology, 9, eadg8817. doi:10.1126/sciimmunol.adg8817. https://pubmed.ncbi.nlm.nih.gov/38640251/
2. Wu, Jingxia, Ma, Sicong, Sandhoff, Roger, Samstag, Yvonne, Cui, Guoliang. 2019. Loss of Neurological Disease HSAN-I-Associated Gene SPTLC2 Impairs CD8+ T Cell Responses to Infection by Inhibiting T Cell Metabolic Fitness. In Immunity, 50, 1218-1231.e5. doi:10.1016/j.immuni.2019.03.005. https://pubmed.ncbi.nlm.nih.gov/30952607/
3. Naruse, Hiroya, Ishiura, Hiroyuki, Esaki, Kayoko, Tsuji, Shoji, Toda, Tatsushi. 2024. SPTLC2 variants are associated with early-onset ALS and FTD due to aberrant sphingolipid synthesis. In Annals of clinical and translational neurology, 11, 946-957. doi:10.1002/acn3.52013. https://pubmed.ncbi.nlm.nih.gov/38316966/
4. Zhai, Xingyue, Shen, Ning, Guo, Tao, Meng, Songshu, Du, Sha. 2024. SPTLC2 drives an EGFR-FAK-HBEGF signaling axis to promote ovarian cancer progression. In Oncogene, 44, 679-693. doi:10.1038/s41388-024-03249-0. https://pubmed.ncbi.nlm.nih.gov/39645550/
5. Lü, Guohua, Wu, Ren, Wang, Bing, Wang, Xiaoxiao, Kuang, Lei. 2023. SPTLC2 ameliorates chondrocyte dysfunction and extracellular matrix metabolism disturbance in vitro and in vivo in osteoarthritis. In Experimental cell research, 425, 113524. doi:10.1016/j.yexcr.2023.113524. https://pubmed.ncbi.nlm.nih.gov/36828166/
智鼠故事 
